Company Filing History:
Years Active: 2003-2013
Title: Manisha M Dali: Innovator in Protein Formulations and Prodrug Salts
Introduction
Manisha M Dali is a prominent inventor based in Bridgewater, NJ (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable protein formulations and novel prodrug salts. With a total of 6 patents to her name, her work has the potential to impact the treatment of various immune system diseases.
Latest Patents
Among her latest patents, one focuses on stable protein formulations that include CTLA4Ig molecules. This invention encompasses both lyophilized and liquid formulations designed for administration through various routes, such as intravenous (IV) and subcutaneous (SC) methods. These formulations aim to treat immune system diseases and facilitate tolerance induction. Another notable patent involves Combretastatin A-4 phosphate prodrug salts, which enhance the solubility of combretastatin A-4. These salts are designed to regenerate combretastatin A-4 in vivo under normal physiological conditions, resulting in physiologically tolerable products.
Career Highlights
Manisha M Dali is currently associated with Bristol-Myers Squibb Company, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to improving drug formulations and enhancing therapeutic efficacy.
Collaborations
Throughout her career, she has collaborated with esteemed colleagues, including Charles E Dahlheim and John J Venit. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Manisha M Dali stands out as a leading inventor in the pharmaceutical industry, with her innovative patents paving the way for advancements in drug formulations. Her contributions are vital for the ongoing development of effective treatments for immune system diseases.